Retaane FDA Approval Status
FDA Approved: No
Brand name: Retaane
Generic name: anecortave acetate
Dosage form: Depot Suspension
Treatment for: Macular Degeneration
Retaane (anecortave) is an angiostatic cortisene that inhibits the abnormal growth of blood vessels. Retaane suspension is an investigational treatment for preserving the vision of patients with wet age-related macular degeneration (AMD).
Development timeline for Retaane
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.